Insights On Outsourced Drug Development
-
Bridging The Gap Between Traditional Models And Human Biology
9/3/2024
Whether you are new to Organ-on-a-Chip technology or seeking to expand your expertise, watch to gain the knowledge and insights needed to effectively implement this technology into your research.
-
High-Throughput Pyrogen Testing In A Multimode Microplate Reader
3/20/2026
Explore a faster, high‑sensitivity approach to pyrogen detection that uses an NF‑κB reporter system to measure both endotoxin and non‑endotoxin contaminants to enable shorter workflows.
-
Characterization And Impurity Profiling Of Combined Amylin And GLP-1 Analogs
7/29/2025
GLP-1 receptor agonists are transforming diabetes and weight loss treatment. Discover how to enable precise impurity analysis and characterization of complex, fatty acid-modified peptide therapeutics.
-
KORSCH Virtual Pharma Expo September 2025: Oral Solid Dose Manufacturing And Packaging
9/18/2025
Simulate high-speed tablet production early in development with minimal material. Gain accurate scale-up, faster material characterization, and flexible formulation options—all with one compaction simulator.
-
Seed Train Intensification Using High Cell Density Cryopreservation
8/11/2025
Streamline your upstream bioprocessing with seed train intensification. Discover how high cell density cryopreservation reduces scale-up time, boosts consistency, and enhances manufacturing flexibility.
-
Engineering The Future Of Lipsomal Drug Delivery
5/14/2025
Explore our full collection of case studies to discover how liposome technology is transforming drug delivery across a wide range of therapies.
-
White Paper: Characterization Of Spray Dried Biologics
5/7/2025
Discover how spray drying can transform the formulation of complex biologics by improving stability, delivery, and functionality, with insights into the critical techniques and strategies needed for successful development.
-
Matrigel Dome Assay And Drug Screening Of Colorectal Cancer Organoids
3/31/2025
Using CRC organoids and bioprinting, explore the automation of dome assays to evaluate drug responses and delve into the insights from image-based end-point assays on the efficacy of anti-cancer treatments.
-
EMA Support For SMEs Through Scientific Advice And Early Dialogue
5/6/2026
Discover how early engagement with European regulators helps smaller drug developers reduce uncertainty, clarify requirements, and de‑risk innovative programs through early dialogue.
-
Your AKTA Oligosynt™ System : It's More Than A Machine
2/9/2026
Discover how early choices in oligo synthesis workflows shape performance. Learn what to consider across design, reagents, and system optimization to build a process ready for smooth scale‑up.